FDA Wants More Info on Avedro's Corneal Cross-Linking NDA Medscape "Patients with these sight threatening conditions may require corneal transplant surgery. If approved, the riboflavin ophthalmic solution/KXL System would be the first FDA-approved therapeutic treatment for these orphan indications," the company said. |
